Minute Insight: Masimo Receives FDA De Novo Clearance For Opioid Overdose And Alert System

Masimo is the first company to receive FDA clearance for a device to prevent accidental overdose of opioids. It will be made available to the public in May in addition to a prescription model for health care providers.

Minute Insight
• Source: Informa/Alamy

More from Minute Insights

More from Medtech Insight